Emilie Bouchard is a seasoned professional in clinical operations with extensive experience in leading global clinical studies and strategic planning. Currently serving as Global Study Leader at Pfizer since October 2024, Emilie previously held the position of Vice President of Clinical Operations at Qu Biologics Inc. from March 2023 to March 2025, overseeing the implementation and performance of clinical development strategies. Emilie's prior tenure at Roche from September 2009 to March 2023 included roles such as Senior Clinical Operations Leader and Director for Infectious Diseases, Immunology, and Multiple Sclerosis, where Emilie managed clinical study delivery from Phase 1 to Phase 3 and led multiple global initiatives. Additional experience includes leadership roles at sanofi-aventis, Celmed BioSciences, Merck, and Bodycote. Emilie holds a Bachelor of Science in Biochemistry and Molecular Biology and a Certificate in Business Administration and Management from HEC Montréal.
This person is not in the org chart
This person is not in any teams
This person is not in any offices